Pediatric Nephrology

, Volume 2, Issue 4, pp 425–430 | Cite as

Effects of grwoth hormone therapy and malnutrition on the growth of rats with renal failure

  • David R. Powell
  • Ron G. Rosenfeld
  • Raymond L. Hintz
Original Article


We examined the effects of methionylhuman growth hormone (met-hGH) and malnutrition on the growth of 5/6 nephrectomized rats and sham-operated controls. One group of shamoperated rats (PFS) was pair-fed with a group of nephrectomized rats in renal failure (RF); another group of sham-operated rats was fed ad libitum (ALS), and a final group of rats with renal failure (RF-GH) was treated with 4 IU/day met-hGH. After 4 weeks, RF-GH rats gained 12.3±1.7 cm in length; this was more than the 10.2±1.2 cm gain of RF rats (P<0.05). Ingested food was converted into weight gain more efficiently by RF-GH rats than RF rats (267±26 vs 235±38 mg weight gain/g food intake,P<0.05). RF-GH rats also gained more weight (122±25 g) than RF rats (98±27 g), but this difference was not significant (0.05<P<0.1). Insulin-like growth factor (IGF)-I, glucose and insulin levels were not different between RF and RF-GH rats. Food intake of RF and PFS rats was 64% of ALS intake and was associated with poor gains in weight and length by the PFS and RF groups (relative weight and length gains were ALS>PFS>RF,P<0.05 for all comparisons); this suggests that the poor growth of RF rats when compared with PFS rats was due to factors other, than food intake. Serum IGF-I levels of 771±249 ng/ml in PFS rats were lower than levels of 1109±253 ng/ml found in the ALS group (P<0.05); this is consistent with the malnourished state of PFS rats. Serum IGF-I levels in RF rats (950±236 ng/ml) were not different from ALS or PFS levels despite the fact that RF rats gained less weight and length than either the ALS or PFS rats. We conclude that RF rats increase in length, use ingested calories more efficiently, and fail to develop marked insulin resistance when treated with met-hGH. We find that, in addition to poor food intake, other factors contribute to growth failure in this model of renal failure. Finally, we find that RF rats have normal levels of IGF-I, suggesting that low IGF-I levels are not a major cause of growth failure in rats with renal failure.

Key words

Growth hormone therapy Malnutrition Renal failure Growth 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Potter D, Greifer I (1978) Statural growth in children with renal disease. Kidney Int 14: 334–339Google Scholar
  2. 2.
    Betts PR, Magrath G (1974) Growth pattern and dietary intake in children with chronic renal renal insufficiency. Br Med J 2: 189–193Google Scholar
  3. 3.
    Broyer M (1982) Growth in children with renal insufficiency. Pediatr Clin North Am 29: 991–1003Google Scholar
  4. 4.
    Simmons JM, Wilson CJ, Potter DE, Holliday MA (1971) Relation of calorie deficiency to growth failure in children on hemodialysis and the growth response to calorie supplementation. N Engl J Med 285: 653–656Google Scholar
  5. 5.
    Arnold WC, Danford D, Holliday MA (1983) Effect of caloric supplementation on growth in children with uremia. Kidney Int 24: 205–209Google Scholar
  6. 6.
    Guillot M, Broyer M, Cathelineau L (1980) Nutrition enterale a debit constant en nephrologie pediatrique. Arch Fr Pediatr 37: 479–485Google Scholar
  7. 7.
    Mehls O, Ritz E, Gilli G, Bartholome K, Beissbarth H, Hohenegger M, Schafnitzel W (1980) Nitrogen metabolism and growth in experimental uremia. Int J Pediatr Nephrol 1: 34–42Google Scholar
  8. 8.
    Wang M, Vyhmeister I, Kopple JD, Swendseid ME (1976) Effect of protein intake on weight gain and plasma amino acid levels in uremic rats. Am J Physiol. 230: 1455–1459Google Scholar
  9. 9.
    Schalch DS, Burstein PJ, Tewel SJ, Draznin B, Emler CA (1981) The effect of renal impairment on growth in the rat: relationship to malnutrition and serum somatomedin levels. Endocrinology 108: 1683–1689Google Scholar
  10. 10.
    Schoenle E, Zapf J, Humbel RE, Froesch ER (1982) Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296: 252–253Google Scholar
  11. 11.
    Scheiwiller E, Guler H-P, Merryweather J, Scandella C, Maerkl W, Zapf J, Froesch ER (1986) Growth restoration of insulin-deficient diabetic rats by, recombinant human insulin-like, growth factor I. Nature 323: 169–171Google Scholar
  12. 12.
    Maes M, Underwood L, Gerard G, Ketelslegers J-M (1984) Relationship between plasma somatomedin-C and liver somatogenic binding sites in neonatal rats during malnutrition and after short and long term refeeding. Endocrinology 115: 786–792Google Scholar
  13. 13.
    Goldberg A, Trivedi B, Delmez J, Harter H, Daughaday WH (1982) Uremia reduces insulin-like growth factor-I, increases insulin-like growth factor-II and modifies their serum protein binding. J Clin Endocrinol Metab 55: 1040–1045Google Scholar
  14. 14.
    Lynch R, Furlanetto RW, Travis L, Cinningham R, Mauer S (1983) Serum RIA-somatomedin-C (Sm-C) is depressed in children and adolescents with end stage renal disease. Kidney Int 23: 217Google Scholar
  15. 15.
    Mehls O, Ritz E (1983) Skeletal growth in experimental uremia. Kidney Int [Suppl] 15: S53-S60Google Scholar
  16. 16.
    Powell DR, Rosenfeld RG, Baker B, Hintz RL (1986) Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor (IGF)-I and IGF-II in acid chormatographed uremic serum. J Clin Endocrinol Metab 63: 1186–1192Google Scholar
  17. 17.
    Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RL (1987) Serum concentrations of insulin-like growth factor (IGF)-I, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 10: 287–292Google Scholar
  18. 18.
    Phillips LS, Fusco AC, Unterman, TG, DelGreco F (1984) Somatomedin inhibitor in uremia. J Clin Endocrinol Metab 59: 764–772Google Scholar
  19. 19.
    Samaan NA, Freeman RM (1970) Growth hormone levels in severe renal failure. Metabolism 19: 102–113Google Scholar
  20. 20.
    El-Bishti MM, Counahan R, Bloom SR, Chantler C (1978) Hormonal and metabolic responses to intravenous glucose in children on regular dialysis. Am J Clin Nutr 31: 1865–1869Google Scholar
  21. 21.
    Westervelt FB (1968) Abnormal carbohydrate metabolism in uremia. Am J Clin Nutr 21: 423–427Google Scholar
  22. 22.
    DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J (1980) Glucose intolerance in uremia: site and mechanism. Am J Clin Nutr 33: 1438–1445Google Scholar
  23. 23.
    Laouari D, Kleinknecht C, Gubler MC, Ravet V, Broyer M (1982) Effect of protein intake on the growth of uremic rats. Int J Pediatr Nephrol 3: 263–269Google Scholar
  24. 24.
    Flodh H, Johansson H-E, Jonsson M, Ekvarn S (1982) General toxicity in rats of biosynthetic and pituitary human growth hormones. In: Gueriguian J (ed) Hormone drugs. US Pharmacopeial Convention, pp 327–334Google Scholar
  25. 25.
    Furlanetto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of Sm-C levels in normals and patients with pituitary disease by RIA. J Clin Invest 60: 648–657Google Scholar
  26. 26.
    Rosenfeld RG, Dollar LA (1982) Characterization, of the somatomedin-C/insulin-like growth factor I (Sm-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by Sm-C/IGF-I and insulin. J Clin Endocrinol Metab 55: 434–440Google Scholar
  27. 27.
    Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194: 495–496Google Scholar
  28. 28.
    Thorell JI, Larson SM (1978) Radioimmunoassay and related techniques. Mosby, St. Louis, p 271Google Scholar
  29. 29.
    Hales CN, Randle PJ (1963) Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88: 137–145Google Scholar
  30. 30.
    Wright A, Lowy G, Fraser T, Spitz I, Rubenstein A, Bersohn I (1968) Serum growth hormone and glucose intolerance in renal failure. Lancet II: 798–800Google Scholar
  31. 31.
    Rosenfeld RG, Wilson DM, Dollar LA, Bennett A, Hintz RL (1982) Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 54: 1033–1038Google Scholar
  32. 32.
    Isakson OG, Lindahl A, Nilsson A, Isgaard J (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8: 426–438Google Scholar
  33. 33.
    Kemp SF, Rosenfeld RG, Liu F, Gaspich S, Hintz RL (1981) Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay. J Clin Endocrinol Metab 52: 616–621Google Scholar
  34. 34.
    Reddan JR, Dziedzic DC (1982) Insulin-like growth factors, IGF-1, IGF-2 and somatomedin-C trigger cell proliferation in mammalian epithelial cells cultured in serum free medium. Exp Cell Res 142: 293–300Google Scholar
  35. 35.
    Soliman AT, Hassan AI, Aref MK, Hintz RL, Rosenfeld RG, Rogol AD (1986) Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20: 1122–1128Google Scholar
  36. 36.
    Schimpff RM, Donnadieu M, Gourmelen M, Girard F (1974) The effects of hGH treatment on somatomedin levels in serum. Horm Metab Res 6: 494–498Google Scholar
  37. 37.
    Powell DR, Lee PDK, Chang D, Liu F, Hintz RL (1987) Antiserum developed for the E peptide of insulin-like growth factor IA prohormone recognizes a serum protein by both immunoblot and radioimmunoassay. J Clin Endocrinol Metab 65: 868–875Google Scholar
  38. 38.
    Baxter RC, Martin JL (1986) Radioimmunoassay of growth hormone-dependent insulinike growth factor binding protein in human plasma. J Clin Invest 78: 1504–1512Google Scholar
  39. 39.
    Gertner JM, Horst RL, Broadus AE, Rasmussen H, Genel M (1979) Parathyroid function and vitamin D metabolism during human growth hormone replacement. J Clin Endocrinol Metab 49: 185–188Google Scholar
  40. 40.
    Christiansen JS, Gammelgaard J, Frandsen M, Orskov H, Parving H-H (1982) Kidney function and size in type I (insulin-dependent) diabetic patients before and during growth hormone administration for one week. Diabetologia 22: 333–337Google Scholar

Copyright information

© IPNA 1988

Authors and Affiliations

  • David R. Powell
    • 1
  • Ron G. Rosenfeld
    • 2
  • Raymond L. Hintz
    • 2
  1. 1.Department of Pediatrics, Section of Nephrology, Baylor College of MedicineDiabetes Research CenterHoustonUSA
  2. 2.Department of Pediatrics, Division of Pediatric EndocrinologyStanford University Medical CenterStanfordUSA

Personalised recommendations